CONSORT diagram. 1, patients without the complete set of baseline forms were excluded; 2, infusion set is the cohort with complete baseline information at the time of data freeze; 3, identifiable tisagenlecleucel batch numbers with available product characteristics; 4, analysis set defined as patients with available follow-up forms after tisagenlecleucel with information related to safety and efficacy outcomes.